Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial - Cheng,A.L.; Kang,Y.K.; Chen,Z. (Lancet Oncol, 2009)